Health Care Technology
Company Overview of Aegate Limited
Aegate Limited operates a secure authentication and traceability service for the pharmaceutical industry in the United Kingdom, Belgium, Greece, and Italy. It offers AegatePROTECT, a real time authentication check of each supplied pack for recalled, expired, or falsified medicines; AegateREACH, a tool to improve treatment adherence and patient education; and AegateASSURE, which communicates urgent regulatory changes, and practical or scientific messages to the pharmacist's computer terminal at point of dispense. The company was founded in 2003 and is based in London, United Kingdom.
123 Buckingham Palace Road
London, SW1W 9SR
Founded in 2003
Key Executives for Aegate Limited
Chief Channels and Partner Officer
Managing Director of Aegate Italy
Chief Pharmaceutical Sales Officer
Compensation as of Fiscal Year 2015.
Aegate Limited Key Developments
Aegate Appoints David Brindley as a Chief Scientific Officer
Jan 5 16
Aegate appointed Dr. David Brindley to the role of Chief Scientific Officer. Dr. Brindley will be responsible for leading the company's' dedicated Hospital Business Unit. David is an international industrial and research leader in healthcare translation. Specifically, at the intersection of novel therapeutic platforms and supporting their efficacious and rapid deployment utilising e-health technologies. He led the worlds first deployment of a medicines authentication system in secondary care, producing the internationally recognised Good Authentication Practice (GAPTM) guidelines. David leads the development and provision of Aegates services in secondary care, pharmacovigilance, bio-manufacturing and training.
European Medicines Verification Organisation Selects Aegate as Service Provider to Implement Medicines Authentication in Europe
Jun 22 15
Aegate have been appointed by the European Medicines Verification Organisation (EMVO) as a selected Service Provider for the supply of the Advanced National Blueprint Service. Aegate's National Blueprint Service will ensure an end-to-end national system of medicines authentication at point of dispense, ensuring patient safety at the last point of the legal pharmaceutical supply chain.
Aegate Appoints Mark Kroes as Chief Pharmaceutical Sales Officer
May 6 15
Aegate announced that Mark Kroes has joined the company as Chief Pharmaceutical Sales Officer. Mark will lead the sales of all value added commercial services to individual pharmaceutical companies. Mark comes to Aegate from Cegedim where he was the Global VP of the Customer Information Unit. He has extensive experience in the sector and joined Cegedim when they acquired his former company, Dendrite.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries